We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Credo Technology Group
CRDO
$33.1B
| $402K | 0.01% |
4,338
-85,729
| -95% | -$5M |
|
1277
Invesco S&P SmallCap Momentum ETF
XSMO
$2.94B
| $400K | 0.01% |
+5,878
| New | +$375K |
|
1278
Expeditors International
EXPD
$22.3B
| $398K | 0.01% |
+3,480
| New | +$390K |
|
1279
Federated Hermes
FHI
$4.56B
| $396K | 0.01% |
+8,928
| New | +$367K |
|
1280
Gen Digital
GEN
$16.5B
| $394K | 0.01% |
+13,402
| New | +$366K |
|
1281
FirstCash
FCFS
$8.77B
| $392K | 0.01% |
+2,902
| New | +$371K |
|
1282
Independent Bank
INDB
$4.04B
| $389K | 0.01% |
+6,188
| New | +$376K |
|
1283
Dana Inc
DAN
$2.88B
| $387K | 0.01% |
22,591
-4,857
| -18% | -$72.5K |
|
1284
Community Trust Bancorp
CTBI
$1.42B
| $387K | 0.01% |
+7,320
| New | +$368K |
|
1285
NovoCure
NVCR
$1.77B
| $387K | 0.01% |
21,727
-1,765
| -8% | -$30.8K |
|
1286
Victory Capital Holdings
VCTR
$6.09B
| $387K | 0.01% |
+6,072
| New | +$365K |
|
1287
Itaú Unibanco
ITUB
$89.8B
| $385K | 0.01% |
+58,370
| New | +$356K |
|
1288
Assured Guaranty
AGO
$3.73B
| $382K | 0.01% |
+4,389
| New | +$374K |
|
1289
Akamai
AKAM
$15.6B
| $382K | 0.01% |
+4,792
| New | +$372K |
|
1290
CareDx
CDNA
$1.83B
| $381K | 0.01% |
+19,474
| New | +$346K |
|
1291
Kohl's
KSS
$2.16B
| $378K | 0.01% |
+44,598
| New | +$343K |
|
1292
United Bankshares
UBSI
$6.69B
| $378K | 0.01% |
+10,365
| New | +$364K |
|
1293
Global Ship Lease
GSL
$1.56B
| $377K | 0.01% |
14,347
+5,402
| +60% | +$126K |
|
1294
Sportradar
SRAD
$4.42B
| $377K | 0.01% |
+13,425
| New | +$319K |
|
1295
Indivior Pharmaceuticals
INDV
$4.74B
| $375K | 0.01% |
25,443
+3,769
| +17% | +$43.9K |
|
1296
Home BancShares
HOMB
$6.3B
| $373K | 0.01% |
+13,110
| New | +$365K |
|
1297
Heartland Express
HTLD
$1.01B
| $372K | 0.01% |
43,064
+29,002
| +206% | +$249K |
|
1298
Grand Canyon Education
LOPE
$4.22B
| $370K | 0.01% |
1,960
+592
| +43% | +$110K |
|
1299
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
| $370K | 0.01% |
+2,250
| New | +$356K |
|
1300
Constellation Brands
STZ
$22.5B
| $368K | 0.01% |
+2,262
| New | +$406K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.